02666 UNI MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.16X | Oper Margin | 21.5% |
|---|---|---|---|
| LT Debt/Equity | 173.7% | Net Margin | 14.9% |
| Total Debt/Equity | 302.8% | Return on Equity | 11.8% |
| Price/Book | 0.65X | Return on Assets | 2.4% |
| (HKD 6.240) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 2,160.76 | 2,227.46 | 2,117.29 | 2,244.67 | 1,955.30 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -3.0 | +5.2 | -5.7 | +14.8 | +17.5 |
| Earnings Per Share (HKD) | 1.142 | 1.178 | 1.119 | 1.207 | 1.139 |
| Earnings Per Share Growth (%) | -3.0 | +5.2 | -7.3 | +5.9 | +17.5 |
| Dividend Per Share (HKD) | 0.350 | 0.350 | 0.340 | 0.360 | 0.310 |
| P/E* (X) | 5.46 | 5.30 | 5.57 | 5.17 | 5.48 |
| Yield (%) | 5.61 | 5.61 | 5.45 | 5.77 | 4.97 |
| Dividend Share (%) | 30.64 | 29.72 | 30.38 | 29.83 | 27.21 |
| Book NAV (HKD) | 9.657 | 9.135 | 8.287 | 8.473 | 7.448 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 13,663 | 13,650 | +0.1 | 12,073 |
| Operating Result | 2,881 | 2,860 | +0.7 | 2,690 |
| Associates | 26.564 | 6.38 | +316.4 | 13.462 |
| Profit Before Taxation | 2,907 | 2,866 | +1.4 | 2,703 |
| Taxation | 648.785 | 667.141 | -2.8 | 617.326 |
| Profit /( Loss) After Taxation | 2,258 | 2,199 | +2.7 | 2,086 |
| Minority Interests | 154.377 | 88.735 | +74.0 | 126.128 |
| Net Profit | 2,032 | 2,021 | +0.5 | 1,888 |
| Earnings Per Share () | 1.1423 | 1.1776 | -3.0 | 1.1193 |
| Dividend Per Share () | 0.3500 | 0.3500 | +0.0 | 0.3400 |
| Announcement Date | 2025-03-26 | 2024-03-27 | NA | 2023-03-29 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
